BRM bonds
Below is the list of BRISTOL-MYRS SQUIB corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
— | 963 K | 99.27% | 3.20% | 2026-06-15 | 1.74 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 130.24% | 4.25% | 2049-10-26 | 500 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 104.25% | 3.20% | 2026-06-15 | 5.95 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 20 K | 107.69% | 6.13% | 2038-05-01 | 219.25 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 2.63 M | 97.31% | 3.40% | 2029-07-26 | 2.37 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 15 K | 113.79% | 6.88% | 2097-08-01 | 62.42 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | — | 30 K | 82.51% | 5.25% | 2043-08-15 | 4.06 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | — | 20 K | 84.30% | 4.55% | 2048-02-20 | 37.2 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | — | 8 K | 87.60% | 5.00% | 2045-08-15 | 15.71 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 750 K | 95.71% | 3.40% | 2029-07-26 | 26.56 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 62 K | 99.04% | 3.45% | 2027-11-15 | 517.67 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 40 K | 88.77% | 4.63% | 2044-05-15 | 744.72 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 114.77% | 3.45% | 2027-11-15 | 67 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 116.80% | 3.90% | 2028-02-20 | 6.07 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | — | 100 K | 79.04% | 4.63% | 2044-05-15 | 3.69 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 76 K | 106.23% | 5.70% | 2040-10-15 | 151.01 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 6 K | 85.84% | 4.55% | 2048-02-20 | 1.24 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 20 K | 93.24% | 5.25% | 2043-08-15 | 218.37 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 419 K | 81.05% | 4.25% | 2049-10-26 | 3.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 406 K | 100.05% | 4.83% | 2026-02-20 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 8 K | 75.29% | 3.25% | 2042-08-01 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | — | 60 K | 98.08% | 3.45% | 2027-11-15 | 16.55 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 9 K | 107.95% | 5.88% | 2036-11-15 | 279.22 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 456 K | 87.21% | 1.45% | 2030-11-13 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 141.76% | 5.00% | 2045-08-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 3 K | 83.57% | 4.35% | 2047-11-15 | 1.24 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | — | 97 K | 99.13% | 3.90% | 2028-02-20 | 43.84 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 4.49 M | 99.71% | 3.90% | 2028-02-20 | 1.45 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 237 K | 94.74% | 5.00% | 2045-08-15 | 741.72 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | — | 5 K | 80.09% | 4.35% | 2047-11-15 | 13.57 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 8.99 M | 89.17% | 4.13% | 2039-06-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 137.60% | 4.55% | 2048-02-20 | 9.5 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | — | 10 K | 93.18% | 5.70% | 2040-10-15 | 2.3 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 0 | 122.76% | 4.13% | 2039-06-15 | 4.4 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 272 K | 103.34% | 6.80% | 2026-11-15 | 255.95 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. | |
— | 57 K | 99.29% | 0.75% | 2025-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 87.04% | 4.50% | 2044-03-01 | 341.52 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 97.19% | 5.65% | 2064-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 71.37% | 3.90% | 2062-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 101.07% | 4.90% | 2027-02-22 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 79.21% | 3.55% | 2042-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 72.66% | 3.70% | 2052-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 91.24% | 2.95% | 2032-03-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 98.60% | 3.25% | 2027-02-27 | 512.28 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 99.29% | 5.50% | 2044-02-22 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 85.85% | 1.75% | 2035-05-15 | 575 M EUR | 1,000.00 EUR | 100,000.00 EUR | Bristol Myers Squibb Co. | |
— | 0 | 68.85% | 2.35% | 2040-11-13 | 750 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 107.89% | 5.90% | 2033-11-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 107.21% | 6.25% | 2053-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 102.51% | 4.90% | 2029-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 58.61% | 2.55% | 2050-11-13 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 97.23% | 5.55% | 2054-02-22 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 106.76% | 5.75% | 2031-02-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 107.93% | 6.40% | 2063-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 100.18% | 4.95% | 2026-02-20 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 94.26% | 1.13% | 2027-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 103.66% | 5.10% | 2031-02-22 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 102.55% | 5.20% | 2034-02-22 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |